Clinical Trial Update: Effects of Quinapril 40 mg With Alpha Lipoic Acid or Placebo on Diabetes and Hypertension [NA]

View source ↗

Summary

Clinical trial update indicating a completed study evaluating quinapril 40 mg with alpha-lipoic acid versus placebo for diabetes mellitus and hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Hypertension

Drugs mentioned

• Alpha Lipoic Acid (alpha-lipoic acid)
• Quinapril (quinapril)

Snippet

Sponsor: InVasc Therapeutics, Inc. | Conditions: Diabetes, Hypertension | NA | Status: COMPLETED